Showing 11 to 20 of 24 Search Results:
-
Fluorosis and periostitis deformans as complications of prolonged voriconazole treatment
Rad B, Saleem M, Grant S, Florkowski C, Coates P, Gordon D, Rankin W.
Journal Name: Annals of Clinical Biochemistry
Publish Date: September 2015
Volume/Page: 52(Pt 5):611-4.
Type: Human Study, Case Report
Categories: Bones/Joints, Arthritis, Pharmaceuticals, Sources of Exposure, Voriconazole
-
Voriconazole-induced periostitis after allogeneic stem cell transplantation
Baird JH, Birnbaum BK, Porter DL, Frey NV.
Journal Name: American Journal of Hematology
Publish Date: June 2015
Volume/Page: 90(6):574-5.
Type: Human Study, Case Report
Categories: Bones/Joints, Arthritis, Total Body Burden, Sources of Exposure, Pharmaceuticals, Voriconazole
-
Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole
Tarlock K, Johnson D, Cornell C, Parnell S, Meshinchi S, Baker KS, Englund JA.
Journal Name: Pediatric Blood & Cancer
Publish Date: May 2015
Volume/Page: 62(5):918-20.
Type: Human Study, Case Report
Categories: Bones/Joints, Arthritis, Skeletal Fluorosis, Total Body Burden, Sources of Exposure, Tissue F Levels, Pharmaceuticals, Serum-F, Pharmaceuticals, Voriconazole
-
Voriconazole
Journal Name: Reactions Weekly
Publish Date: February 21, 2015
Volume/Page: 1539(1):292.
Type: Human Study, Case Report
Categories: Bones/Joints, Arthritis, Pharmaceuticals, Sources of Exposure, Voriconazole
-
Sodium Fluoride F 18: Summary of Use during Lactation.
Journal Name: Drugs and Lactation Database (LactMed) [Internet]
Publish Date: November 7, 2014
Type: Human Study, Review
Categories: Susceptible Populations, Total Body Burden, Pharmacokinetics, Sources of Exposure, Tissue F Levels, Breast Milk, Pharmaceuticals
-
Flutemetamol F 18. Summary of Use during Lactation.
Publish Date: November 7, 2014
Type: Human Study, Review
Categories: Susceptible Populations, Total Body Burden, Sources of Exposure, Tissue F Levels, Breast Milk, Pharmaceuticals, Pharmaceuticals
-
Painful periostitis in the setting of chronic voriconazole therapy
Skaug M, Spak C, Oza U.
Journal Name: Baylor University Medical Center Proceedings
Publish Date: 2014
Volume/Page: 27(4):350-52.
Type: Human Study, Case Report
Categories: Bones/Joints, Arthritis, Skeletal Fluorosis, Total Body Burden, Sources of Exposure, Pharmaceuticals, Voriconazole
-
Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
Wermers RA, Cooper K, Razonable RR, Deziel PJ, Whitford GM, Kremers WK, Moyer TP.
Journal Name: Clinical Infectious Diseases
Publish Date: March 1, 2011
Volume/Page: 52(5):604-11.
Type: Human Study, Case Report
Categories: Bones/Joints, Bone-F, Pharmaceuticals, Serum-F, Voriconazole
-
Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
Ayub A, Kenney CV, McKiernan FE.
Journal Name: Journal of Clinical Rheumatology
Publish Date: March 2011
Volume/Page: 17(2):73-5.
Type: Human Study, Case Report
Categories: Bones/Joints, Pharmaceuticals, Sources of Exposure, Periostitis deformans, Voriconazole
-
Inorganic fluoride kinetics and renal tubular function after sevoflurane anesthesia in chronic renal failure patients receiving hemodialysis
Nishiyama T, Aibiki M, Hanaoka K.
Journal Name: Anesthesia and Analgesia
Publish Date: September 1996
Volume/Page: 83(3):574-7
Type: Human Study
Categories: Kidney, Nephrotoxicity, Risks to Kidney Patients, Dialysis, Pharmaceuticals, anesthetics, Sevoflurane